Predict your next investment

Corporation
epygen.com

See what CB Insights has to offer

Funds

1

About Epygen Biotech

Epygen Biotech will be launching its entry Biosimilar molecule Recombinant Streptokinase (rSK). Its expertise on recombinant protein is utilized for purification of molecules, making them affordable for patients in the region.

Epygen Biotech Headquarter Location

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Epygen Biotech Fund History

1 Fund History

Epygen Biotech has 1 fund, including Epygen Biotech Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Epygen Biotech Fund

1

Closing Date

Fund

Epygen Biotech Fund

Fund Type

Status

Amount

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.